David Rescott
Stock Analyst at Baird
(3.57)
# 856
Out of 4,974 analysts
68
Total ratings
54.55%
Success rate
5.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MDT Medtronic | Maintains: Neutral | $94 → $96 | $92.85 | +3.39% | 7 | Aug 20, 2025 | |
PEN Penumbra | Maintains: Buy | $300 → $310 | $279.72 | +10.83% | 31 | Jul 30, 2025 | |
EW Edwards Lifesciences | Maintains: Neutral | $78 → $79 | $80.96 | -2.42% | 5 | Jul 25, 2025 | |
BSX Boston Scientific | Maintains: Outperform | $117 → $123 | $107.29 | +14.64% | 8 | Jul 24, 2025 | |
HAE Haemonetics | Initiates: Outperform | $87 | $54.08 | +60.87% | 1 | Jun 26, 2025 | |
LIVN LivaNova | Maintains: Outperform | $55 → $61 | $58.18 | +4.86% | 4 | May 8, 2025 | |
MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $92.14 | +19.38% | 3 | Apr 25, 2025 | |
ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $454.52 | +26.51% | 3 | Apr 23, 2025 | |
SIBN SI-BONE | Maintains: Buy | $25 → $26 | $16.31 | +59.41% | 6 | Dec 22, 2023 |
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94 → $96
Current: $92.85
Upside: +3.39%
Penumbra
Jul 30, 2025
Maintains: Buy
Price Target: $300 → $310
Current: $279.72
Upside: +10.83%
Edwards Lifesciences
Jul 25, 2025
Maintains: Neutral
Price Target: $78 → $79
Current: $80.96
Upside: -2.42%
Boston Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $117 → $123
Current: $107.29
Upside: +14.64%
Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $54.08
Upside: +60.87%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55 → $61
Current: $58.18
Upside: +4.86%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $92.14
Upside: +19.38%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $454.52
Upside: +26.51%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $16.31
Upside: +59.41%